The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2025

Global BCG Vaccine for Tuberculosis (TB) Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1720917

No of Pages : 108

Ask Your Query

Synopsis
BCG Vaccine for Tuberculosis (TB) provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing TB.
Due to the COVID-19 pandemic, the global BCG Vaccine for Tuberculosis (TB) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe BCG Vaccine for Tuberculosis (TB) market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe BCG Vaccine for Tuberculosis (TB) landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Immune Type accounting for % of the BCG Vaccine for Tuberculosis (TB) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of BCG Vaccine for Tuberculosis (TB) include Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, AJ Vaccines, Serum Institute of India, Intervax, GSBPL and Statens Serum Institute, etc. In terms of revenue, the global 3 largest players have a % market share of BCG Vaccine for Tuberculosis (TB) in 2021.
This report focuses on BCG Vaccine for Tuberculosis (TB) volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall BCG Vaccine for Tuberculosis (TB) market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global BCG Vaccine for Tuberculosis (TB) Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type

  • Immune Type
  • Therapy Type

Segment by Application

  • Hospitals
  • Clinics
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Merck
  • Sanofi Pasteur
  • Japan BCG Lab
  • China National Biotec
  • AJ Vaccines
  • Serum Institute of India
  • Intervax
  • GSBPL
  • Statens Serum Institute
  • Biomed Lublin
  • ANLIS Malbran
  • Fundação Ataulpho de Paiva
  • BB-NCIPD
  • Taj Pharmaceuticals
  • Bio Farma
  • Microgen
  • Torlakinstitut
  • Institut Pasteur de Tunis
  • IVAC
Index

1 BCG Vaccine for Tuberculosis (TB) Market Overview
1.1 Product Overview and Scope of BCG Vaccine for Tuberculosis (TB)
1.2 BCG Vaccine for Tuberculosis (TB) Segment by Type
1.2.1 Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Immune Type
1.2.3 Therapy Type
1.3 BCG Vaccine for Tuberculosis (TB) Segment by Application
1.3.1 Global BCG Vaccine for Tuberculosis (TB) Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global BCG Vaccine for Tuberculosis (TB) Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine for Tuberculosis (TB) Revenue 2017-2028
1.4.2 Global BCG Vaccine for Tuberculosis (TB) Sales 2017-2028
1.4.3 BCG Vaccine for Tuberculosis (TB) Market Size by Region: 2017 Versus 2021 Versus 2028
2 BCG Vaccine for Tuberculosis (TB) Market Competition by Manufacturers
2.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2017-2022)
2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Manufacturers (2017-2022)
2.3 Global BCG Vaccine for Tuberculosis (TB) Average Price by Manufacturers (2017-2022)
2.4 Manufacturers BCG Vaccine for Tuberculosis (TB) Manufacturing Sites, Area Served, Product Type
2.5 BCG Vaccine for Tuberculosis (TB) Market Competitive Situation and Trends
2.5.1 BCG Vaccine for Tuberculosis (TB) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest BCG Vaccine for Tuberculosis (TB) Players Market Share by Revenue
2.5.3 Global BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG Vaccine for Tuberculosis (TB) Retrospective Market Scenario by Region
3.1 Global BCG Vaccine for Tuberculosis (TB) Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global BCG Vaccine for Tuberculosis (TB) Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.3.1 North America BCG Vaccine for Tuberculosis (TB) Sales by Country
3.3.2 North America BCG Vaccine for Tuberculosis (TB) Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.4.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country
3.4.2 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Region
3.5.1 Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region
3.5.2 Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.6.1 Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country
3.6.2 Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Market Facts & Figures by Country
3.7.1 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country
3.7.2 Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global BCG Vaccine for Tuberculosis (TB) Historic Market Analysis by Type
4.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2022)
4.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Type (2017-2022)
4.3 Global BCG Vaccine for Tuberculosis (TB) Price by Type (2017-2022)
5 Global BCG Vaccine for Tuberculosis (TB) Historic Market Analysis by Application
5.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2022)
5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Application (2017-2022)
5.3 Global BCG Vaccine for Tuberculosis (TB) Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Merck BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 AJ Vaccines
6.5.1 AJ Vaccines Corporation Information
6.5.2 AJ Vaccines Description and Business Overview
6.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.5.4 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.5.5 AJ Vaccines Recent Developments/Updates
6.6 Serum Institute of India
6.6.1 Serum Institute of India Corporation Information
6.6.2 Serum Institute of India Description and Business Overview
6.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.6.5 Serum Institute of India Recent Developments/Updates
6.7 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Intervax BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.7.5 Intervax Recent Developments/Updates
6.8 GSBPL
6.8.1 GSBPL Corporation Information
6.8.2 GSBPL Description and Business Overview
6.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.8.4 GSBPL BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.8.5 GSBPL Recent Developments/Updates
6.9 Statens Serum Institute
6.9.1 Statens Serum Institute Corporation Information
6.9.2 Statens Serum Institute Description and Business Overview
6.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.9.5 Statens Serum Institute Recent Developments/Updates
6.10 Biomed Lublin
6.10.1 Biomed Lublin Corporation Information
6.10.2 Biomed Lublin Description and Business Overview
6.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.10.5 Biomed Lublin Recent Developments/Updates
6.11 ANLIS Malbran
6.11.1 ANLIS Malbran Corporation Information
6.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.11.4 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.11.5 ANLIS Malbran Recent Developments/Updates
6.12 Fundação Ataulpho de Paiva
6.12.1 Fundação Ataulpho de Paiva Corporation Information
6.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.12.5 Fundação Ataulpho de Paiva Recent Developments/Updates
6.13 BB-NCIPD
6.13.1 BB-NCIPD Corporation Information
6.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.13.4 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.13.5 BB-NCIPD Recent Developments/Updates
6.14 Taj Pharmaceuticals
6.14.1 Taj Pharmaceuticals Corporation Information
6.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.14.5 Taj Pharmaceuticals Recent Developments/Updates
6.15 Bio Farma
6.15.1 Bio Farma Corporation Information
6.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.15.5 Bio Farma Recent Developments/Updates
6.16 Microgen
6.16.1 Microgen Corporation Information
6.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Microgen BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.16.5 Microgen Recent Developments/Updates
6.17 Torlakinstitut
6.17.1 Torlakinstitut Corporation Information
6.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.17.5 Torlakinstitut Recent Developments/Updates
6.18 Institut Pasteur de Tunis
6.18.1 Institut Pasteur de Tunis Corporation Information
6.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.18.5 Institut Pasteur de Tunis Recent Developments/Updates
6.19 IVAC
6.19.1 IVAC Corporation Information
6.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Description and Business Overview
6.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Sales, Revenue and Gross Margin (2017-2022)
6.19.4 IVAC BCG Vaccine for Tuberculosis (TB) Product Portfolio
6.19.5 IVAC Recent Developments/Updates
7 BCG Vaccine for Tuberculosis (TB) Manufacturing Cost Analysis
7.1 BCG Vaccine for Tuberculosis (TB) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of BCG Vaccine for Tuberculosis (TB)
7.4 BCG Vaccine for Tuberculosis (TB) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 BCG Vaccine for Tuberculosis (TB) Distributors List
8.3 BCG Vaccine for Tuberculosis (TB) Customers
9 BCG Vaccine for Tuberculosis (TB) Market Dynamics
9.1 BCG Vaccine for Tuberculosis (TB) Industry Trends
9.2 BCG Vaccine for Tuberculosis (TB) Market Drivers
9.3 BCG Vaccine for Tuberculosis (TB) Market Challenges
9.4 BCG Vaccine for Tuberculosis (TB) Market Restraints
10 Global Market Forecast
10.1 BCG Vaccine for Tuberculosis (TB) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Type (2023-2028)
10.1.2 Global Forecasted Revenue of BCG Vaccine for Tuberculosis (TB) by Type (2023-2028)
10.2 BCG Vaccine for Tuberculosis (TB) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Application (2023-2028)
10.2.2 Global Forecasted Revenue of BCG Vaccine for Tuberculosis (TB) by Application (2023-2028)
10.3 BCG Vaccine for Tuberculosis (TB) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of BCG Vaccine for Tuberculosis (TB) by Region (2023-2028)
10.3.2 Global Forecasted Revenue of BCG Vaccine for Tuberculosis (TB) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global BCG Vaccine for Tuberculosis (TB) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global BCG Vaccine for Tuberculosis (TB) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global BCG Vaccine for Tuberculosis (TB) Market Competitive Situation by Manufacturers in 2021
Table 5. Global BCG Vaccine for Tuberculosis (TB) Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Manufacturers (2017-2022)
Table 7. Global BCG Vaccine for Tuberculosis (TB) Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market BCG Vaccine for Tuberculosis (TB) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers BCG Vaccine for Tuberculosis (TB) Manufacturing Sites and Area Served
Table 11. Manufacturers BCG Vaccine for Tuberculosis (TB) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global BCG Vaccine for Tuberculosis (TB) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCG Vaccine for Tuberculosis (TB) as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022) & (K Units)
Table 16. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2022)
Table 17. Global BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2022)
Table 19. North America BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units)
Table 20. North America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2022)
Table 21. North America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2022)
Table 23. Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units)
Table 24. Europe BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2022)
Table 25. Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2022)
Table 31. Latin America BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units)
Table 32. Latin America BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2022)
Table 33. Latin America BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Country (2017-2022)
Table 39. Global BCG Vaccine for Tuberculosis (TB) Sales by Type (2017-2022) & (K Units)
Table 40. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2022)
Table 41. Global BCG Vaccine for Tuberculosis (TB) Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Type (2017-2022)
Table 43. Global BCG Vaccine for Tuberculosis (TB) Price by Type (2017-2022) & (US$/Unit)
Table 44. Global BCG Vaccine for Tuberculosis (TB) Sales (K Units) by Application (2017-2022)
Table 45. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Application (2017-2022)
Table 46. Global BCG Vaccine for Tuberculosis (TB) Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Application (2017-2022)
Table 48. Global BCG Vaccine for Tuberculosis (TB) Price by Application (2017-2022) & (US$/Unit)
Table 49. Merck Corporation Information
Table 50. Merck Description and Business Overview
Table 51. Merck BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Merck BCG Vaccine for Tuberculosis (TB) Product
Table 53. Merck Recent Developments/Updates
Table 54. Sanofi Pasteur Corporation Information
Table 55. Sanofi Pasteur Description and Business Overview
Table 56. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product
Table 58. Sanofi Pasteur Recent Developments/Updates
Table 59. Japan BCG Lab Corporation Information
Table 60. Japan BCG Lab Description and Business Overview
Table 61. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product
Table 63. Japan BCG Lab Recent Developments/Updates
Table 64. China National Biotec Corporation Information
Table 65. China National Biotec Description and Business Overview
Table 66. China National Biotec BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. China National Biotec BCG Vaccine for Tuberculosis (TB) Product
Table 68. China National Biotec Recent Developments/Updates
Table 69. AJ Vaccines Corporation Information
Table 70. AJ Vaccines Description and Business Overview
Table 71. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product
Table 73. AJ Vaccines Recent Developments/Updates
Table 74. Serum Institute of India Corporation Information
Table 75. Serum Institute of India Description and Business Overview
Table 76. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product
Table 78. Serum Institute of India Recent Developments/Updates
Table 79. Intervax Corporation Information
Table 80. Intervax Description and Business Overview
Table 81. Intervax BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Intervax BCG Vaccine for Tuberculosis (TB) Product
Table 83. Intervax Recent Developments/Updates
Table 84. GSBPL Corporation Information
Table 85. GSBPL Description and Business Overview
Table 86. GSBPL BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. GSBPL BCG Vaccine for Tuberculosis (TB) Product
Table 88. GSBPL Recent Developments/Updates
Table 89. Statens Serum Institute Corporation Information
Table 90. Statens Serum Institute Description and Business Overview
Table 91. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product
Table 93. Statens Serum Institute Recent Developments/Updates
Table 94. Biomed Lublin Corporation Information
Table 95. Biomed Lublin Description and Business Overview
Table 96. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product
Table 98. Biomed Lublin Recent Developments/Updates
Table 99. ANLIS Malbran Corporation Information
Table 100. ANLIS Malbran Description and Business Overview
Table 101. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product
Table 103. ANLIS Malbran Recent Developments/Updates
Table 104. Fundação Ataulpho de Paiva Corporation Information
Table 105. Fundação Ataulpho de Paiva Description and Business Overview
Table 106. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product
Table 108. Fundação Ataulpho de Paiva Recent Developments/Updates
Table 109. BB-NCIPD Corporation Information
Table 110. BB-NCIPD Description and Business Overview
Table 111. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 112. BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product
Table 113. BB-NCIPD Recent Developments/Updates
Table 114. Taj Pharmaceuticals Corporation Information
Table 115. Taj Pharmaceuticals Description and Business Overview
Table 116. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 117. Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product
Table 118. Taj Pharmaceuticals Recent Developments/Updates
Table 119. Bio Farma Corporation Information
Table 120. Bio Farma Description and Business Overview
Table 121. Bio Farma BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 122. Bio Farma BCG Vaccine for Tuberculosis (TB) Product
Table 123. Bio Farma Recent Developments/Updates
Table 124. Microgen Corporation Information
Table 125. Microgen Description and Business Overview
Table 126. Microgen BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 127. Microgen BCG Vaccine for Tuberculosis (TB) Product
Table 128. Microgen Recent Developments/Updates
Table 129. Torlakinstitut Corporation Information
Table 130. Torlakinstitut Description and Business Overview
Table 131. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 132. Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product
Table 133. Torlakinstitut Recent Developments/Updates
Table 134. Institut Pasteur de Tunis Corporation Information
Table 135. Institut Pasteur de Tunis Description and Business Overview
Table 136. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 137. Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product
Table 138. Institut Pasteur de Tunis Recent Developments/Updates
Table 139. IVAC Corporation Information
Table 140. IVAC Description and Business Overview
Table 141. IVAC BCG Vaccine for Tuberculosis (TB) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 142. IVAC BCG Vaccine for Tuberculosis (TB) Product
Table 143. IVAC Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. BCG Vaccine for Tuberculosis (TB) Distributors List
Table 147. BCG Vaccine for Tuberculosis (TB) Customers List
Table 148. BCG Vaccine for Tuberculosis (TB) Market Trends
Table 149. BCG Vaccine for Tuberculosis (TB) Market Drivers
Table 150. BCG Vaccine for Tuberculosis (TB) Market Challenges
Table 151. BCG Vaccine for Tuberculosis (TB) Market Restraints
Table 152. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Type (2023-2028)
Table 154. Global BCG Vaccine for Tuberculosis (TB) Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Application (2023-2028)
Table 158. Global BCG Vaccine for Tuberculosis (TB) Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global BCG Vaccine for Tuberculosis (TB) Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share Forecast by Region (2023-2028)
Table 162. Global BCG Vaccine for Tuberculosis (TB) Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of BCG Vaccine for Tuberculosis (TB)
Figure 2. Global BCG Vaccine for Tuberculosis (TB) Market Share by Type in 2021 & 2028
Figure 3. Immune Type Product Picture
Figure 4. Therapy Type Product Picture
Figure 5. Global BCG Vaccine for Tuberculosis (TB) Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global BCG Vaccine for Tuberculosis (TB) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global BCG Vaccine for Tuberculosis (TB) Market Size (2017-2028) & (US$ Million)
Figure 11. Global BCG Vaccine for Tuberculosis (TB) Sales (2017-2028) & (K Units)
Figure 12. BCG Vaccine for Tuberculosis (TB) Sales Share by Manufacturers in 2021
Figure 13. Global BCG Vaccine for Tuberculosis (TB) Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest BCG Vaccine for Tuberculosis (TB) Players: Market Share by Revenue in 2021
Figure 15. BCG Vaccine for Tuberculosis (TB) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region (2017-2022)
Figure 17. Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Region in 2021
Figure 18. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region (2017-2022)
Figure 19. Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Region in 2021
Figure 20. United States BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Colombia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Turkey BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Saudi Arabia BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. UAE BCG Vaccine for Tuberculosis (TB) Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Sales Market Share of BCG Vaccine for Tuberculosis (TB) by Type (2017-2022)
Figure 44. Manufacturing Cost Structure of BCG Vaccine for Tuberculosis (TB)
Figure 45. Manufacturing Process Analysis of BCG Vaccine for Tuberculosis (TB)
Figure 46. BCG Vaccine for Tuberculosis (TB) Industrial Chain Analysis
Figure 47. Channels of Distribution
Figure 48. Distributors Profiles
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock